Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 12:21 AM
NCT ID:
NCT01038258
Eligibility Criteria:
Inclusion Criteria:
* Recently diagnosed breast carcinoma that will receive neoadjuvant chemotherapy based on: Tumors size greater than 2 cms; Locally advanced tumors, Tumors close to or invading chest wall or areola and/or Inflammatory Breast cancer.
* 18 years of age.
* Available for follow-up visits
* Able to comply with study requirements.
* Have signed an IRB approved written informed consent form
Exclusion Criteria:
* Any significant medical or psychiatric illness, which would prevent the patient from giving informed consent or following the study procedures.
* Pregnant and Nursing women.
* No restriction will be placed on the chemotherapy regimen used although we expect that most patients will receive Anthracycline based regimens.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01038258
Study Brief:
Protocol Section:
NCT01038258